Ascend Wellness Holdings: Buy, Sell or Hold?
Ascend Wellness Holdings’ (Ascend Wellness Holdings Stock Quote, Chart, News, Analysts, Financials CSE:AAWH.U) return to year-over-year revenue growth and improving retail sales support its expansion strategy, according to Haywood Securities analyst Neal Gilmer, although pricing pressures and the cost of opening new stores could weigh on future margins.
Gilmer maintained his “Buy” rating and US$1.00 target on the U.S. cannabis producer, saying third-quarter results were largely in line with expectations and reflected improving performance across its retail operations.
Ascend reported third-quarter revenue of US$130-million, up 4.2% year-over-year and 3.1% from the previous quarter. Revenue was in line with Gilmer’s US$130.6-million estimate and consensus of US$129.6-million. Adjusted EBITDA reached US$31.1-million, exceeding his US$29.4-million forecast, while the Adjusted EBITDA margin improved to 23.9% from 23.1% in the second quarter. Adjusted gross margin rose to 48.4%, ahead of Gilmer’s 47% estimate. Retail revenue increased 16.8% year-over-year to US$97.8-million, while wholesale revenue declined 21.4% to US$32.2-million.
In his Nov. 13 report, Gilmer said the company’s decision to concentrate on expanding its presence in established markets is contributing to improved retail performance.
“Ascend is a U.S. multi-state operator that has established operations in seven states,” he said. “To date the Company has focused on acquiring assets and infrastructure in limited licensed markets.” “Management is focused on going deep across its current markets while keeping an eye on acquisition opportunities in other states.”
Ascend operated 56 retail locations at the end of September, including partner locations, but has since expanded to 61 dispensaries, exceeding its target of 60 for the year. The five recent openings included one location each in New Jersey, Illinois and Ohio, along with two in Massachusetts.
Gilmer said the company is concentrating on markets where additional stores can strengthen its competitive position and improve returns.
“Management remains focused on key flagship locations to drive strong retail store economics,” he said. “To date the Company has reported strong retail numbers and remains committed to building brands and maintaining market share across its portfolio, while evaluating opportunities for new locations.”
Ascend expects fourth-quarter revenue to increase between 1% and 2%, supported by the contribution from new stores, although seasonal discounting and continued pricing pressure could partially offset the gains. Management expects Adjusted EBITDA margins to remain consistent with third-quarter levels and forecasts approximately US$20-million in capital expenditures for fiscal 2026.
The company generated US$5.4-million in operating cash flow during the quarter after making a US$19.1-million semi-annual interest payment. Ascend ended September with US$63.6-million in cash and reported net debt of US$260.4-million, excluding unamortized deferred financing costs.
The analyst thinks the company’s cash generation and debt maturity schedule provide some flexibility as it pursues further expansion. “Ascend has generated positive operating cash flow in eleven of the past thirteen quarters,” he said. “The Company has no significant debt maturities until July 2029, when its Senior Secured Notes mature.”
Following the results, Gilmer reduced his fiscal 2026 revenue estimate to US$505.1-million from US$510.2-million and his Adjusted EBITDA forecast to US$118.2-million from US$118.7-million. For fiscal 2027, he maintained a revenue forecast of approximately US$538.2-million, compared with US$538.3-million previously, but lowered his Adjusted EBITDA estimate to US$135-million from US$138.3-million. He also reduced his projected 2027 Adjusted EBITDA margin to 25.1% from 25.7%, reflecting continued pricing pressure and expenses associated with opening new dispensaries.
Gilmer said Ascend’s established markets, including Ohio’s adult-use cannabis market, offer opportunities for additional growth, while future regulatory changes could open new markets.
Disclosure: Nick Waddell owns shares of Ascend.
-30-
Nick Waddell
Founder of Cantech Letter
Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.
